Cargando…

PES1 reduces CD8(+) T cell infiltration and immunotherapy sensitivity via interrupting ILF3-IL15 complex in esophageal squamous cell carcinoma

BACKGROUND: Although immune checkpoint blockade (ICB) therapy has brought survival benefits to patients with specific cancer types, most of cancer patients remain refractory to the ICB therapy, which is largely attributed to the immunosuppressive tumor microenvironment. Thereby, it is urgent to prof...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Ning, Hua, Rong, Yang, Yang, Liu, Zhi-Chao, Pan, Jie, Yu, Bo-Yao, Sun, Yi-Feng, Xie, Dong, Wang, Yan, Li, Zhi-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037800/ https://www.ncbi.nlm.nih.gov/pubmed/36959575 http://dx.doi.org/10.1186/s12929-023-00912-8

Ejemplares similares

Metabolomic Characterization Reveals ILF2 and ILF3 Affected Metabolic Adaptions in Esophageal Squamous Cell Carcinoma
por: Zang, Bin, et al.
Publicado: (2021)

ILF2 and ILF3 are autoantigens in canine systemic autoimmune disease
por: Bremer, Hanna D., et al.
Publicado: (2018)

Immunotherapy for Esophageal Squamous Cell Carcinoma
por: Kojima, Takashi, et al.
Publicado: (2017)

The Accumulation and Prognosis Value of Tumor Infiltrating IL-17 Producing Cells in Esophageal Squamous Cell Carcinoma
por: Lv, Lin, et al.
Publicado: (2011)

Esophageal Squamous Cell Carcinoma with Marked Eosinophil Infiltration
por: Fukuchi, Minoru, et al.
Publicado: (2011)

The positive feedback loop between ILF3 and lncRNA ILF3-AS1 promotes melanoma proliferation, migration, and invasion
por: Gao, Guozhen, et al.
Publicado: (2018)

Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation
por: Jia, Rong, et al.
Publicado: (2019)

CD103(+) tumor-infiltrating lymphocytes predict favorable prognosis in patients with esophageal squamous cell carcinoma
por: Chu, Yifan, et al.
Publicado: (2019)

Characterization of the Immune Cell Infiltration Landscape in Esophageal Squamous Cell Carcinoma
por: Sui, Zhilin, et al.
Publicado: (2022)

Pes Planus and Pes Cavus: An Anatomical and Clinical Study
por: Barwell, Richard
Publicado: (1898)

Expression and Clinical Significance of ILF2 in Gastric Cancer
por: Yin, Zi-huan, et al.
Publicado: (2017)

Ferroptosis patterns and tumor microenvironment infiltration characterization in esophageal squamous cell cancer
por: Zhang, Lu-Lu, et al.
Publicado: (2022)

Perioperative immunotherapy for esophageal squamous cell carcinoma: Now and future
por: Liu, Yong
Publicado: (2023)

Comprehensive Analyses Reveal Effects on Tumor Immune Infiltration and Immunotherapy Response of APOBEC Mutagenesis and Its Molecular Mechanisms in Esophageal Squamous Cell Carcinoma
por: Yang, Jie, et al.
Publicado: (2023)

PES1 is a biomarker of head and neck squamous cell carcinoma and is associated with the tumor microenvironment
por: He, Yaodong, et al.
Publicado: (2023)

Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy
por: Yang, Ying, et al.
Publicado: (2020)

Involvement of Indoleamine 2,3-Dioxygenase in Impairing Tumor-Infiltrating CD8(+) T-Cell Functions in Esophageal Squamous Cell Carcinoma
por: Zhang, Ge, et al.
Publicado: (2011)

Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis
por: Li, Rong, et al.
Publicado: (2021)

YKT6, as a potential predictor of prognosis and immunotherapy response for oral squamous cell carcinoma, is related to cell invasion, metastasis, and CD8+ T cell infiltration
por: Yang, Zongcheng, et al.
Publicado: (2021)

Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma
por: Chen, Kaiyan, et al.
Publicado: (2017)

Esophageal luminal stenosis is an independent prognostic factor in esophageal squamous cell carcinoma
por: Yang, Yu-Shang, et al.
Publicado: (2017)

lncRNA AK085865 Promotes Macrophage M2 Polarization in CVB3-Induced VM by Regulating ILF2-ILF3 Complex-Mediated miRNA-192 Biogenesis
por: Zhang, Yingying, et al.
Publicado: (2020)

Trained Immunity of IL-12-, IL-15-, and IL-18-Induced CD(3)+CD(56)+ NKT-Like Cells
por: Zhu, Siyu, et al.
Publicado: (2022)

Inducible expression of immediate early genes is regulated through dynamic chromatin association by NF45/ILF2 and NF90/NF110/ILF3
por: Wu, Ting-Hsuan, et al.
Publicado: (2019)

The Functionalities and Clinical Significance of Tumor-Infiltrating Immune Cells in Esophageal Squamous Cell Carcinoma
por: Zhang, Jishuai, et al.
Publicado: (2021)

Esophageal mycobiome landscape and interkingdom interactions in esophageal squamous cell carcinoma
por: Rao, Wen-Qing, et al.
Publicado: (2023)

IL7 signaling confers polyfunctionality to antitumor CD4+ T cells
por: Zhou, Gang, et al.
Publicado: (2014)

IL-15 in the Combination Immunotherapy of Cancer
por: Waldmann, Thomas A., et al.
Publicado: (2020)

Heterodimeric IL-15 in Cancer Immunotherapy
por: Bergamaschi, Cristina, et al.
Publicado: (2021)

Phenotypic profiling and prognostic significance of immune infiltrates in esophageal squamous cell carcinoma
por: Pan, Chuqing, et al.
Publicado: (2021)

ILF2 Directly Binds and Stabilizes CREB to Stimulate Malignant Phenotypes of Liver Cancer Cells
por: Du, Hui, et al.
Publicado: (2019)

PSMD3-ILF3 signaling cascade drives lung cancer cell proliferation and migration
por: Zhang, Jin, et al.
Publicado: (2023)

Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers
por: Zhu, Ying, et al.
Publicado: (2021)

Comparison of neoadjuvant nab‐paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma
por: Yang, Yafan, et al.
Publicado: (2023)

Comprehensive Analysis of Prognostic Value and Immune Infiltration of MMP12 in Esophageal Squamous Cell Carcinoma
por: Mao, Jing-tao, et al.
Publicado: (2022)

Machine Learning and Novel Biomarkers Associated with Immune Infiltration for the Diagnosis of Esophageal Squamous Cell Carcinoma
por: Zhang, Jipeng, et al.
Publicado: (2022)

Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma
por: Huai, Qilin, et al.
Publicado: (2021)

The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma
por: Wang, Jianbo, et al.
Publicado: (2014)

ILF3 promotes gastric cancer proliferation and may be used as a prognostic marker
por: Liu, Yü, et al.
Publicado: (2019)

Immunotherapy for Squamous Esophageal Cancer: A Review
por: Petrillo, Angelica, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qpgtfr9g3esivochi6u1j2valb